A patient with early myoclonic encephalopathy (EME) with a de novo KCNQ2 mutation

Most patients with a KCNQ2 mutation present with seizures starting in the neonatal period with varying severity, ranging from BFNS to Ohtahara syndrome. Furthermore, KCNQ2 appears to be a causative gene for EME.